JAMES MARMORA: Open Payments
NPI 1588674956 · EAST BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,282 in 68 payments from 21 companies in 2025. Trend: 2023 $1,112 · 2024 $1,364 · 2025 $1,282
Food & beverage: $1,282
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $254 |
| AstraZeneca Pharmaceuticals LP | 11 | $185 |
| Amgen Inc. | 3 | $151 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $100 |
| Novo Nordisk Inc | 5 | $82 |
| Bausch Health US, LLC | 4 | $71 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Lilly USA, LLC | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Kowa Pharmaceuticals America, Inc. | 3 | $47 |
Products named: QULIPTA, Repatha, JARDIANCE, FARXIGA, UBRELVY, WELLBUTRIN, Auvelity, AIRSUPRA.
Industry payments across NJ — which companies pay providers there.
